NIPH Stock Overview
The Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products primarily in the Middle East.
The Nile Co. for Pharmaceuticals and Chemical Industries Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م34.42|
|52 Week High||ج.م37.89|
|52 Week Low||ج.م25.01|
|1 Month Change||-3.07%|
|3 Month Change||-3.07%|
|1 Year Change||20.43%|
|3 Year Change||55.82%|
|5 Year Change||90.17%|
|Change since IPO||130.49%|
Recent News & Updates
|NIPH||EG Pharmaceuticals||EG Market|
Return vs Industry: NIPH matched the EG Pharmaceuticals industry which returned 19.7% over the past year.
Return vs Market: NIPH exceeded the EG Market which returned 19.3% over the past year.
|NIPH Average Weekly Movement||6.1%|
|Pharmaceuticals Industry Average Movement||5.1%|
|Market Average Movement||5.8%|
|10% most volatile stocks in EG Market||9.0%|
|10% least volatile stocks in EG Market||3.5%|
Stable Share Price: NIPH is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: NIPH's weekly volatility (6%) has been stable over the past year.
About the Company
|1962||n/a||Hesham Abd Elsayed||https://www.nilepharma.com.eg|
The Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products primarily in the Middle East. The company offers prescription pharmaceutical products, including tablets, capsules, dry syrups, syrups and suspensions, ointments, gels and creams, suppositories, ampoules, drops, parenteral, sachets, biotechnological products, lyophilized products, sterile antibiotic vials, lotions, shampoos, and solutions. It also provides non-prescription pharmaceutical products, such as analgesic and anti-inflammatory, antihistaminic, anthelmintic, antibacterial, antifungal, cardiovascular disorders, central nervous system and antiparkinsonism drugs, oral cavity products, respiratory system disorders, urinary tract disorders, endocrine glands disorders, gastrointestinal tract disorders, muscle relaxants, topical otic and nasal preparations, topical ophthalmological preparations, dermatological preparations, women and men healthcare products, osteoporosis, pediatrics, cosmetics, antiseptics, and immunological products, as well as vitamins and minerals.
The Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary
|NIPH fundamental statistics|
Is NIPH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NIPH income statement (TTM)|
|Cost of Revenue||ج.م654.44m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||8.86|
|Net Profit Margin||10.23%|
How did NIPH perform over the long term?See historical performance and comparison